☰

Laura E. Richert, Ph.D. - Publications

Affiliations: 
2012 Veterinary Molecular Biology Montana State University, Bozeman, MT 
Area:
Immunology, Virology Biology, Cell Biology
Tree Info Grants Similar researchers PubMed Report error

30 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2020 Jahnmatz M, Richert L, Al-Tawil N, Storsaeter J, Colin C, Bauduin C, Thalen M, Solovay K, Rubin K, Mielcarek N, Thorstensson R, Locht C. Safety and immunogenicity of the live attenuated intranasal pertussis vaccine BPZE1: a phase 1b, double-blind, randomised, placebo-controlled dose-escalation study. The Lancet. Infectious Diseases. PMID 32687804 DOI: 10.1016/S1473-3099(20)30274-7  0.312
2020 Sirima SB, Richert L, Chêne A, Konate AT, Campion C, Dechavanne S, Semblat JP, Benhamouda N, Bahuaud M, Loulergue P, Ouédraogo A, Nébié I, Kabore M, Kargougou D, Barry A, et al. PRIMVAC vaccine adjuvanted with Alhydrogel or GLA-SE to prevent placental malaria: a first-in-human, randomised, double-blind, placebo-controlled study. The Lancet. Infectious Diseases. PMID 32032566 DOI: 10.1016/S1473-3099(19)30739-X  0.319
2019 Lhomme E, Hejblum BP, Lacabaratz C, Wiedemann A, Lelièvre JD, Levy Y, Thiébaut R, Richert L. Analyzing cellular immunogenicity in vaccine clinical trials: a new statistical method including non-specific responses for accurate estimation of vaccine effect. Journal of Immunological Methods. 112711. PMID 31809708 DOI: 10.1016/J.Jim.2019.112711  0.357
2019 Thans TVS, Akko JI, Niehrs A, Garcia-Beltran WF, Richert L, Stürzel CM, Ford CT, Li H, Ochsenbauer C, Kappes JC, Hahn BH, Kirchhoff F, Martrus G, Sauter D, Altfeld M, et al. Primary HIV-1 strains use Nef to downmodulate HLA-E surface expression. Journal of Virology. PMID 31375574 DOI: 10.1128/Jvi.00719-19  0.346
2019 Moore CL, Stöhr W, Crook AM, Richert L, Leliévre JD, Pantaleo G, García F, Vella S, Lévy Y, Thiébaut R, McCormack S. Multi-arm, multi-stage randomised controlled trials for evaluating therapeutic HIV cure interventions. The Lancet. Hiv. 6: e334-e340. PMID 31047670 DOI: 10.1016/S2352-3018(19)30082-7  0.337
2018 Flamar AL, Bonnabau H, Zurawski S, Lacabaratz C, Montes M, Richert L, Wiedemann A, Galmin L, Weiss D, Cristillo A, Hudacik L, Salazar A, Peltekian C, Thiebaut R, Zurawski G, et al. HIV-1 T cell epitopes targeted to Rhesus macaque CD40 and DCIR: A comparative study of prototype dendritic cell targeting therapeutic vaccine candidates. Plos One. 13: e0207794. PMID 30500852 DOI: 10.1371/Journal.Pone.0207794  0.413
2018 Ziegler SM, Feldmann CN, Hagen SH, Richert L, Barkhausen T, Goletzke J, Jazbutyte V, Martrus G, Salzberger W, Renné T, Hecher K, Diemert A, Arck PC, Altfeld M. Innate immune responses to toll-like receptor stimulation are altered during the course of pregnancy. Journal of Reproductive Immunology. 128: 30-37. PMID 29886307 DOI: 10.1016/J.Jri.2018.05.009  0.311
2016 Viard JP, Assuied A, Lévy Y, Souberbielle JC, Thiébaut R, Carrat F, Chêne G, Launay O, Richert L. No Positive Association between Vitamin D Level and Immune Responses to Hepatitis B and Streptococcus pneumoniae Vaccination in HIV-Infected Adults. Plos One. 11: e0168640. PMID 27977797 DOI: 10.1371/Journal.Pone.0168640  0.394
2016 Lhomme E, Richert L, Moodie Z, Pasin C, Kalams SA, Morgan C, Self S, De Rosa SC, Thiébaut R. Early CD4+ T Cell Responses Are Associated with Subsequent CD8+ T Cell Responses to an rAd5-Based Prophylactic Prime-Boost HIV Vaccine Strategy. Plos One. 11: e0152952. PMID 27124598 DOI: 10.1371/Journal.Pone.0152952  0.387
2016 Zurawski G, Zurawski S, Flamar AL, Richert L, Wagner R, Tomaras GD, Montefiori DC, Roederer M, Ferrari G, Lacabaratz C, Bonnabau H, Klucar P, Wang Z, Foulds KE, Kao SF, et al. Targeting HIV-1 Env gp140 to LOX-1 Elicits Immune Responses in Rhesus Macaques. Plos One. 11: e0153484. PMID 27077384 DOI: 10.1371/Journal.Pone.0153484  0.4
2015 Winston A, Stöhr W, Antinori A, Arenas-Pinto A, Llibre JM, Amieva H, Cabié A, Williams I, Di Perri G, Tellez MJ, Rockstroh J, Babiker A, Pozniak A, Raffi F, Richert L, et al. Host and disease factors are associated with cognitive function in European HIV-infected adults prior to initiation of antiretroviral therapy. Hiv Medicine. PMID 26611175 DOI: 10.1111/Hiv.12344  0.318
2015 Brezar V, Ruffin N, Richert L, Surenaud M, Lacabaratz C, Palucka K, Thiébaut R, Banchereau J, Levy Y, Seddiki N. Decreased HIV-specific T-regulatory responses are associated with effective DC-vaccine induced immunity. Plos Pathogens. 11: e1004752. PMID 25816350 DOI: 10.1371/Journal.Ppat.1004752  0.382
2015 Richert L, Lhomme E, Fagard C, Lévy Y, Chêne G, Thiébaut R. Recent developments in clinical trial designs for HIV vaccine research. Human Vaccines & Immunotherapeutics. 11: 1022-9. PMID 25751670 DOI: 10.1080/21645515.2015.1011974  0.331
2014 Rynda-Apple A, Harmsen A, Erickson AS, Larson K, Morton RV, Richert LE, Harmsen AG. Regulation of IFN-γ by IL-13 dictates susceptibility to secondary postinfluenza MRSA pneumonia. European Journal of Immunology. 44: 3263-72. PMID 25091976 DOI: 10.1002/Eji.201444582  0.621
2014 Lévy Y, Thiébaut R, Montes M, Lacabaratz C, Sloan L, King B, Pérusat S, Harrod C, Cobb A, Roberts LK, Surenaud M, Boucherie C, Zurawski S, Delaugerre C, Richert L, et al. Dendritic cell-based therapeutic vaccine elicits polyfunctional HIV-specific T-cell immunity associated with control of viral load. European Journal of Immunology. 44: 2802-10. PMID 25042008 DOI: 10.1002/Eji.201344433  0.428
2014 Chakrabarti LA, Boucherie C, Bugault F, Cumont MC, Roussillon C, Breton G, Patey O, Chêne G, Richert L, Lortholary O. Biomarkers of CD4+ T-cell activation as risk factors for tuberculosis-associated immune reconstitution inflammatory syndrome. Aids (London, England). 28: 1593-602. PMID 24865974 DOI: 10.1097/Qad.0000000000000311  0.338
2014 Richert L, Doussau A, Lelièvre JD, Arnold V, Rieux V, Bouakane A, Lévy Y, Chêne G, Thiébaut R. Accelerating clinical development of HIV vaccine strategies: methodological challenges and considerations in constructing an optimised multi-arm phase I/II trial design. Trials. 15: 68. PMID 24571662 DOI: 10.1186/1745-6215-15-68  0.355
2014 Richert L, Brault M, Mercié P, Dauchy FA, Bruyand M, Greib C, Dabis F, Bonnet F, Chêne G, Dehail P. Handgrip strength is only weakly correlated with physical function in well-controlled hiv infection: Anrs co3 aquitaine cohort Journal of Acquired Immune Deficiency Syndromes. 65. PMID 24419068 DOI: 10.1097/Qai.0B013E3182A03Db8  0.307
2014 Richert LE, Rynda-Apple A, Harmsen AL, Han S, Wiley JA, Douglas T, Larson K, Morton RV, Harmsen AG. CD11c⁺ cells primed with unrelated antigens facilitate an accelerated immune response to influenza virus in mice. European Journal of Immunology. 44: 397-408. PMID 24222381 DOI: 10.1002/Eji.201343587  0.665
2013 Richert LE, Harmsen AL, Rynda-Apple A, Wiley JA, Servid AE, Douglas T, Harmsen AG. Inducible bronchus-associated lymphoid tissue (iBALT) synergizes with local lymph nodes during antiviral CD4+ T cell responses. Lymphatic Research and Biology. 11: 196-202. PMID 24364842 DOI: 10.1089/Lrb.2013.0015  0.62
2013 Richert L, Hue S, Hocini H, Raimbault M, Lacabaratz C, Surenaud M, Wiedemann A, Tisserand P, Durier C, Salmon D, Lelièvre JD, Chêne G, Thiébaut R, Lévy Y. Cytokine and gene transcription profiles of immune responses elicited by HIV lipopeptide vaccine in HIV-negative volunteers. Aids (London, England). 27: 1421-31. PMID 23759749 DOI: 10.1097/Qad.0B013E32835F5B60  0.372
2013 Richert L, Thiebaut R. Is the current use of 'positivity' thresholds meaningful for evaluating HIV-vaccine immunogenicity endpoints? Aids (London, England). 27: 1362-5. PMID 23759712 DOI: 10.1097/Qad.0B013E328360D52E  0.308
2013 Bonnet F, Amieva H, Marquant F, Bernard C, Bruyand M, Dauchy FA, Mercié P, Greib C, Richert L, Neau D, Catheline G, Dehail P, Dabis F, Morlat P, Dartigues JF, et al. Cognitive disorders in HIV-infected patients: are they HIV-related? Aids (London, England). 27: 391-400. PMID 23079813 DOI: 10.1097/Qad.0B013E32835B1019  0.301
2013 Richert L, Brault M, Mercié P, Dauchy FA, Bruyand M, Greib C, Dabis F, Bonnet F, Chêne G, Dehail P. Evolution of locomotor performances in HIV-1 infected adults included in the ANRS CO3 Aquitaine cohort Annals of Physical and Rehabilitation Medicine. 56. DOI: 10.1016/J.Rehab.2013.07.470  0.318
2012 Rynda-Apple A, Dobrinen E, McAlpine M, Read A, Harmsen A, Richert LE, Calverley M, Pallister K, Voyich J, Wiley JA, Johnson B, Young M, Douglas T, Harmsen AG. Virus-like particle-induced protection against MRSA pneumonia is dependent on IL-13 and enhancement of phagocyte function. The American Journal of Pathology. 181: 196-210. PMID 22642909 DOI: 10.1016/J.Ajpath.2012.03.018  0.564
2012 Richert LE, Servid AE, Harmsen AL, Rynda-Apple A, Han S, Wiley JA, Douglas T, Harmsen AG. A virus-like particle vaccine platform elicits heightened and hastened local lung mucosal antibody production after a single dose. Vaccine. 30: 3653-65. PMID 22465748 DOI: 10.1016/J.Vaccine.2012.03.035  0.656
2011 Richert L, Dehail P, Mercié P, Dauchy FA, Bruyand M, Greib C, Dabis F, Bonnet F, Chêne G. High frequency of poor locomotor performance in HIV-infected patients. Aids (London, England). 25: 797-805. PMID 21330905 DOI: 10.1097/Qad.0B013E3283455Dff  0.335
2011 Nozères A, Richert L, Delleci C, Mercié P, Bruyand M, Bonnet F, Neau D, Cazanave C, Lazaro E, Dehail P. Evolution of locomotive performance in HIV-infected patients in the ANRS CO3 Aquitaine Cohort Annals of Physical and Rehabilitation Medicine. 54. DOI: 10.1016/J.Rehab.2011.07.573  0.324
2009 Wiley JA, Richert LE, Swain SD, Harmsen A, Barnard DL, Randall TD, Jutila M, Douglas T, Broomell C, Young M, Harmsen A. Inducible bronchus-associated lymphoid tissue elicited by a protein cage nanoparticle enhances protection in mice against diverse respiratory viruses. Plos One. 4: e7142. PMID 19774076 DOI: 10.1371/Journal.Pone.0007142  0.677
2008 Richert L, Bouteloup V, Thiébaut R, Chêne G. Methodological issues of non-inferiority trials in HIV-infected patients: a need for consensus? Aids (London, England). 22: 996-7. PMID 18453863 DOI: 10.1097/Qad.0B013E3282Ff6490  0.333
Show low-probability matches.